As MYC and FOXM1 have critical roles in both cell cycle progression and motility [26], these analyses suggest that NANOG-mediated PCa cell reprogramming may likely intersect with and engage both transcriptional programs. The gene discussed is MYC; the disease is posterior cortical atrophy.